Prostate Cancer Resource Center
Q & A Cases from The Bethesda Review of Oncology

A 63- year- old male with metastatic castration- resistant prostate cancer (metastatic to the scapula and 3 ribs) is currently being treated with ADT and enzalutamide 160 mg/ daily. 

Take the Quiz

A 65- year- old male with mCRPC including metastasis to the pelvis, spine, and ribs has recently started treatment with enzalutamide. 

Take the Quiz

A patient is seeing you in follow- up for his mCPRC including metastasis to the lungs, liver, and spine. 

Take the Quiz

Loading